Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Evotec SE

Market Cap 807M 926M 744M 699M 1.31B 87.25B 1.32B 8.85B 3.44B 43B 3.47B 3.4B 149B P/E 2026 *
-6.39x
P/E 2027 * -23.2x
Enterprise Value 821M 942M 757M 712M 1.33B 88.8B 1.34B 9B 3.5B 43.76B 3.54B 3.46B 152B EV / Sales 2026 *
1.11x
EV / Sales 2027 * 1.07x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day-4.04%
1 week-3.53%
Current month-13.47%
1 month-2.37%
3 months+4.52%
6 months-11.80%
Current year-17.03%
1 week 4.53
Extreme 4.53
4.9
1 month 4.53
Extreme 4.53
5.33
Current year 4.02
Extreme 4.017
6.66
1 year 4.02
Extreme 4.017
7.8
3 years 4.02
Extreme 4.017
24.45
5 years 4.02
Extreme 4.017
45.7
10 years 3.3
Extreme 3.3
45.7
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO - 01/05/2026
Chief Operating Officer - 01/05/2026
Director TitleAgeSince
Director/Board Member 58 19/06/2019
Director/Board Member 64 01/06/2021
Director/Board Member 43 22/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-4.59%-3.53% - - 975M
-0.34%-1.48%-12.18%-13.39% 43.44B
+3.31%+13.04%+316.43%+562.02% 33.54B
-1.70%-7.90%+8.87%-22.34% 28.48B
+2.84%+2.48%+6.32%+34.93% 29.2B
-0.57%+3.77%+12.66%+20.42% 25.34B
-0.14%+10.03% - - 14.36B
+0.68%-1.19%+54.47%+107.47% 13.05B
+0.54%-3.88%+3.69%+2.24% 12.67B
-0.26%+1.09%+105.03%+80.69% 12.28B
Average +0.07%+0.80%+61.91%+96.51% 23.6B
Weighted average by Cap. +0.64%+0.79%+65.10%+109.05%

Financials

2026 *2027 *
Net sales 738M 847M 680M 640M 1.2B 79.78B 1.2B 8.09B 3.14B 39.32B 3.18B 3.11B 136B 818M 939M 754M 709M 1.33B 88.46B 1.34B 8.97B 3.48B 43.59B 3.52B 3.45B 151B
Net income -113M -130M -104M -98.18M -184M -12.25B -185M -1.24B -482M -6.04B -488M -477M -20.92B -30.42M -34.91M -28.04M -26.38M -49.35M -3.29B -49.69M -334M -130M -1.62B -131M -128M -5.62B
Net Debt 14.3M 16.41M 13.18M 12.4M 23.2M 1.55B 23.36M 157M 60.91M 762M 61.6M 60.28M 2.64B 69.32M 79.57M 63.91M 60.11M 112M 7.5B 113M 760M 295M 3.7B 299M 292M 12.81B
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,526
Date Price Change Volume
18/06/26 4.530 -4.59% 5,980
17/06/26 4.748 +1.80% 410
16/06/26 4.664 -3.40% 1,730
15/06/26 4.828 +3.25% 0
12/06/26 4.676 +0.17% 600
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
4.538EUR
Average target price
6.443EUR
Spread / Average Target
+41.98%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!